Be Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Be Biopharma's estimated annual revenue is currently $20M per year.
- Be Biopharma's estimated revenue per employee is $155,000
- Be Biopharma's total funding is $52M.
Employee Data
- Be Biopharma has 129 Employees.
- Be Biopharma grew their employee count by 6% last year.
Be Biopharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | Co-founder & VP, Strategy & Operations | Reveal Email/Phone |
4 | CFO & Head Corporate Strategy | Reveal Email/Phone |
5 | VP Clinical Development Operations | Reveal Email/Phone |
6 | VP, Business Operations | Reveal Email/Phone |
7 | VP, External Manufacturing & Supply Chain | Reveal Email/Phone |
8 | SVP, Rare Disease & Early Pipeline Research | Reveal Email/Phone |
9 | SVP, Technical Development | Reveal Email/Phone |
10 | Director External Manufacturing and MSAT | Reveal Email/Phone |
Be Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Be Biopharma?
Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
keywords:N/A
$52M
Total Funding
129
Number of Employees
$20M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Be Biopharma News
Greenwald, however, is taking a long-term view, betting that interest in gene therapy research will be there once the downturn is over. The...
Be Biopharma, a Cambridge, MA-based developer of Engineered B Cell Medicines (BeCM), closed a $130m financing.
--(BUSINESS WIRE)--Be Biopharma (Be Bio), a pioneer in the discovery and development of Engineered B Cell Medicines (BeCM), today announced...
Be Biopharma, a Cambridge, MA-based company developing B cells as medicines, raised $52m in Series A financing. The round was led by Atlas Venture and RA Capital Management joined by Alta Partners, Longwood Fund and Takeda Ventures. The company plans to use the funds to precisely engineer B ce ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.4M | 129 | 1% | N/A |
#2 | $7.5M | 129 | -5% | N/A |
#3 | $41.9M | 129 | -30% | N/A |
#4 | $15M | 129 | 5% | N/A |
#5 | $7.5M | 129 | 21% | N/A |